Femasys Inc. Faces Delisting Concerns
Ticker: FEMY · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1339005
| Field | Detail |
|---|---|
| Company | Femasys Inc (FEMY) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $35.0 million, $2.5 million, $500,000, $8.0 million |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, financial-statements
TL;DR
Femasys might be delisted - big trouble brewing.
AI Summary
Femasys Inc. filed an 8-K on October 21, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Suwanee, GA.
Why It Matters
This filing indicates potential issues with Femasys Inc.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.
Key Numbers
- 001-40492 — SEC File Number (Identifies Femasys Inc.'s filing with the SEC.)
- 11-3713499 — EIN (Employer Identification Number for Femasys Inc.)
Key Players & Entities
- Femasys Inc. (company) — Registrant
- October 20, 2025 (date) — Earliest event reported
- October 21, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024 (address) — Principal executive offices
- 770-500-3910 (phone_number) — Principal executive offices telephone number
FAQ
What specific listing rule or standard has Femasys Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Femasys Inc. has failed to satisfy, only that a notice has been issued.
What are the potential consequences of failing to meet listing standards for Femasys Inc.?
The primary consequence is the potential delisting of the company's securities from the exchange where they are traded.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 20, 2025.
What is the principal business address of Femasys Inc.?
The principal business address is 3950 Johns Creek Court, Suite 100, Suwanee, GA 30024.
Does this filing include financial statements?
Yes, the filing explicitly states that 'Financial Statements and Exhibits' are being filed as part of this 8-K.
Filing Stats: 823 words · 3 min read · ~3 pages · Grade level 13.3 · Accepted 2025-10-21 09:16:10
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share FEMY NASDAQ Indicate by
- $35.0 million — common stock had been below the minimum $35.0 million requirement for continued listing on Th
- $2.5 million — ): (i) stockholders' equity of at least $2.5 million or (ii) net income of $500,000 in the m
- $500,000 — east $2.5 million or (ii) net income of $500,000 in the most recently completed fiscal y
- $8.0 million — nts and warrants with gross proceeds of $8.0 million as further detailed in a Form 8-K filed
- $5.2 million — 15, 2025 would have been approximately $5.2 million on a pro forma basis, which meets the m
- $2.5 million — forma basis, which meets the minimum of $2.5 million in stockholders' equity requirement for
Filing Documents
- ef20057473_8k.htm (8-K) — 31KB
- 0001140361-25-038733.txt ( ) — 161KB
- femy-20251020.xsd (EX-101.SCH) — 4KB
- femy-20251020_lab.xml (EX-101.LAB) — 22KB
- femy-20251020_pre.xml (EX-101.PRE) — 16KB
- ef20057473_8k_htm.xml (XML) — 4KB
01
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on May 19, 2025, the Femasys Inc. (the "Company") received a written notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") that for the last 30 consecutive business days, the Market Value of Listed Securities ("MVLS") for the Company's common stock had been below the minimum $35.0 million requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the "Minimum MVLS Requirement"). Additionally, the Company had not met either of the alternative Nasdaq continued listing standards under Nasdaq Listing Rule 5550(b)(2): (i) stockholders' equity of at least $2.5 million or (ii) net income of $500,000 in the most recently completed fiscal year, or in two of the three most recently completed fiscal years. The Company believes that, after taking into account the previously disclosed underwritten offering of common stock, pre-funded warrants and warrants with gross proceeds of $8.0 million as further detailed in a Form 8-K filed on August 27, 2025 and subsequent warrant exercises, and based on pro forma financial data available to the Company, the Company's stockholders' equity as of October 15, 2025 would have been approximately $5.2 million on a pro forma basis, which meets the minimum of $2.5 million in stockholders' equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq will continue to monitor the Company's ongoing compliance with the stockholders' equity requirement and, if at the time of its next periodic report, the Company does not evidence compliance, it may be subject to delisting. Safe Harbor Statement This Current Report on Form 8-K contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements related to the Company's belief tha
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Femasys Inc. By: /s/ Kathy Lee-Sepsick Names: Kathy Lee-Sepsick Title: Chief Executive Officer Date: October 21, 2025